This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Landec Corporation Reports First Quarter Fiscal Year 2012 Results

Yes. Between September 22, 2011 and October 3, 2011, the Company purchased 604,768 shares of Landec Common Stock at a total cost of $3.3 million.

8) What are Landec’s priorities for the next 12 to 24 months?

Our goals are as follows: (1) grow Lifecore’s business by utilizing Lifecore’s strengths in ophthalmology, viscoelastic materials and sterile filling, (2) grow Apio’s food business and maintain Apio’s margins, (3) support Chiquita with its roll-out plans for avocados, (4) support Landec Ag in targeting top seed treatment and crop protection companies, (5) continue to invest in polymer chemistry R&D, (6) find new applications for BreatheWay packaging technology and Intelimer polymer technology that can be commercialized through Landec’s subsidiaries or third party partners, (7) find new investment opportunities for growth and margin enhancement, and (8) maintain a strong balance sheet. We see growth opportunities and we are continuing to expand our investment in R&D to take advantage of these opportunities, while continuing the shift in revenue mix to higher margin businesses.

9) How do the results by line of business for the three months ended August 28, 2011 compare with the same period last year?

The results are as follows (unaudited and in thousands):

Three months ended 8/28/11

Three months ended 8/29/10
Apio Value Added(a) $ 43,363 $ 40,558
Apio Export (b)   21,355       16,483  
Total Apio 64,718 57,041
Lifecore 7,121 6,385
Tech. Licensing (c)   1,462       1,527  
Total Revenues 73,301 64,953
Gross Profit:
Apio Value Added 6,059 6,363
Apio Export   1,014       932  
Total Apio 7,073 7,295
Lifecore 2,715 2,995
Tech. Licensing   1,462       1,527  
Total Gross Profit 11,250 11,817
Apio 270 223
Lifecore 1,086 1,054
Tech. Licensing   977       955  
Total R&D 2,333 2,232
Apio 3,350 3,021
Lifecore 994 989
Tech. Licensing 111 118
Corporate   1,589       1,524  
Total S,G&A 6,044 5,652
Other (d):
Apio 201 (71 )
Lifecore (173 ) (258 )
Corporate   (1,089 )     (1,300 )
Total Other (1,061 ) (1,629 )
Net Income (Loss):
Apio 3,654 3,980
Lifecore 462 694
Tech. Licensing 374 454
Corporate   (2,678 )     (2,824 )
Net Income $ 1,812     $ 2,304  

a) Apio’s Value-Added business includes revenues and gross profit from Apio Cooling LP. and Apio Packaging.

b) Apio’s Export business includes its commission-based commodity export business.

c) Included in Tech. Licensing is the Intellicoat license fees from Monsanto.

d) Included in Other are net interest income/(expense), dividend income, non-operating income/(expense) and income tax expense.

7 of 8

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $95.18 1.60%
FB $117.44 -0.95%
GOOG $692.33 -0.84%
TSLA $232.12 -4.00%
YHOO $36.02 -1.40%


Chart of I:DJI
DOW 17,750.91 -140.25 -0.78%
S&P 500 2,063.37 -18.06 -0.87%
NASDAQ 4,763.2240 -54.37 -1.13%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs